Physician profile
Mark J Libassi
NPI 1215967682
$4,812.64
in general payments reported to CMS, 2019-2025
13 companies · $20.92 in 2025
The $20.92 reported for 2025 was less than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $800 · 2020: $250 · 2021: $329 · 2022: $148 · 2023: $3,178 · 2024: $87.68 · 2025: $20.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,493 · Education: $1,000 · Food and Beverage: $777 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,492.90 |
| Education | $1,000.00 |
| Food and Beverage | $777.07 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,195.54 | 2019-2023 | Da Vinci Surgical System, Davinci Xi |
| W. L. Gore & Associates, INC. | $152.51 | 2021-2023 | Gore Enform Preperitoneal Biomaterial |
| Ethicon US, LLC | $106.52 | 2020-2023 | Echelon Flex, Linx Reflux Management System |
| Smith+Nephew, INC. | $90.14 | 2019-2024 | Stravix Pl, Grafix Pl, Stravix Mesh |
| Davol INC. | $56.48 | 2021-2022 | |
| Baxter Healthcare | $37.35 | 2022 | |
| Organogenesis INC. | $36.95 | 2022 | |
| Conmed Corporation | $36.23 | 2024 | Airseal |
| Takeda Pharmaceuticals U.S.A., INC. | $34.87 | 2022 | |
| Solventum Corporation | $20.92 | 2025 | V.A.C.Ulta, Prevena |
| Medtronic, INC. | $18.20 | 2022 | |
| Endo Pharmaceuticals INC. | $14.07 | 2020 | |
| Covidien Lp | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Libassi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.